ADVFN US – Market Content Editor
-
Tilray Shares Drop After Seeking Extension to Meet Nasdaq Listing Requirements
Tilray Brands Inc (NASDAQ:TLRY) stock fell 12.8% following the company’s announcement that it has requested an extension to regain compliance with Nasdaq’s minimum share price rules. The cannabis and consumer goods company is considering several options, including a potential stockholder-approved reverse stock split, to maintain its Nasdaq listing. Tilray’s shares have been trading below the…
-
Schrödinger Stock Plummets After Halting Key Leukemia Drug Program
Schrödinger Inc (NASDAQ:SDGR) shares dropped 13.7% following the company’s announcement that it is discontinuing development of its CDC7 inhibitor, SGR-2921, which was being evaluated in a Phase 1 study for leukemia patients. The decision comes after two treatment-related deaths occurred in the Phase 1 dose-escalation trial involving patients with relapsed/refractory acute myeloid leukemia (AML) or…
-
Ulta Beauty Stock Dips as Target Partnership Set to End in 2026
Ulta Beauty (NASDAQ:ULTA) shares dropped 2% Thursday morning following the announcement that the company will not renew its shop-in-shop partnership with Target (NYSE:TGT) when the current agreement expires in August 2026. The partnership, which began in 2021, will continue until its expiration, with Ulta Beauty at Target locations operating in-store and online at Target.com. Customers…
-
Beam Therapeutics Stock Surges After FDA Grants RMAT Designation
Beam Therapeutics Inc. (NASDAQ:BEAM) shares jumped 12% following the announcement that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BEAM-101, the company’s investigational cell therapy for sickle cell disease. The RMAT designation, which comes after an earlier orphan drug designation, provides Beam with opportunities for closer FDA…
-
Lazydays Reports Narrower Q2 Loss as Margins Improve
Lazydays Holdings, Inc. (NASDAQ:GORV) posted a second-quarter net loss of $6.67 per share on revenue of $131.3 million Thursday, showing progress in its turnaround efforts despite significantly lower sales volumes. Shares edged up 0.95% in after-hours trading following the results. Revenue declined 44.3% year-over-year from $235.6 million in Q2 2024, reflecting the company’s streamlined footprint…
-
Oncology Institute Shares Drop 7% as Earnings Miss Despite Revenue Growth
The Oncology Institute, Inc. (NASDAQ:TOI) saw its shares fall 7.07% in pre-market trading Thursday after reporting second-quarter earnings that fell short of analyst expectations, despite posting revenue above forecasts. The value-based community oncology provider reported a loss of $0.15 per share for Q2, missing estimates of a $0.09 loss by $0.06. Revenue, however, reached $119.8…
-
Samsonite Q2 Sales Fall, EBITDA Meets Expectations
Samsonite (USOTC:SMSEY) reported a 5% decline in second-quarter sales, slightly outperforming Morgan Stanley’s estimates, while adjusted EBITDA came in at $141 million, in line with expectations. The luggage maker’s EBITDA margin reached 16.3%, below the forecasted 16.8%, mainly due to lower gross profit margins—likely driven by increased promotional activity—and higher distribution costs associated with new…
-
McGraw Hill Exceeds Q1 Revenue Expectations on Digital Growth
McGraw Hill, Inc. (NYSE:MH) surpassed revenue expectations in its first-quarter fiscal 2026 results on Thursday, with total revenue reaching $535.7 million, up 2.4% year-over-year, driven by strong performance in digital and recurring revenue. Shares slipped 0.21% in after-hours trading following the announcement. The education solutions provider reported breakeven earnings per share for the quarter ended…
-
Xunlei Shares Jump After Strong Q2 Revenue Growth
Xunlei Ltd Adr (NASDAQ:XNET) shares surged 13.6% on Thursday following the company’s strong second-quarter results, with revenue climbing 30.6% year-over-year to $104 million, fueled by growth across all business segments. The company reported adjusted earnings of $0.13 per ADS, surpassing analyst expectations of $0.03 per ADS. Revenue growth was broad-based, led by live-streaming and other…
-
Terawulf Shares Jump After $3.7 Billion AI Data Center Deal
Terawulf Inc. (NASDAQ:WULF) saw its stock surge 20% after announcing it had secured two 10-year high-performance computing colocation contracts with AI cloud platform Fluidstack, totaling approximately $3.7 billion in committed revenue. Under the agreements, Terawulf will provide over 200 MW of critical IT capacity at its Lake Mariner data center campus in Western New York.…